M. S. Balayan

1.3k total citations
21 papers, 960 citations indexed

About

M. S. Balayan is a scholar working on Infectious Diseases, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M. S. Balayan has authored 21 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 16 papers in Hepatology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M. S. Balayan's work include Viral gastroenteritis research and epidemiology (16 papers), Hepatitis Viruses Studies and Epidemiology (16 papers) and Viral Infections and Immunology Research (8 papers). M. S. Balayan is often cited by papers focused on Viral gastroenteritis research and epidemiology (16 papers), Hepatitis Viruses Studies and Epidemiology (16 papers) and Viral Infections and Immunology Research (8 papers). M. S. Balayan collaborates with scholars based in Russia, United States and Belarus. M. S. Balayan's co-authors include Tamie Ando, David O. Matson, Ian N. Clarke, Michael J. Studdert, Mary K. Estes, John D. Neill, Shuji Nakata, K. Y. Green, Tamás Berke and S.A. Tsarev and has published in prestigious journals such as FEBS Letters, The Journal of Infectious Diseases and Virology.

In The Last Decade

M. S. Balayan

21 papers receiving 919 citations

Peers

Countries citing papers authored by M. S. Balayan

Since Specialization

Citations

This map shows the geographic impact of M. S. Balayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. S. Balayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. S. Balayan more than expected).

Fields of papers citing papers by M. S. Balayan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. S. Balayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. S. Balayan. The network helps show where M. S. Balayan may publish in the future.

Co-authorship network of co-authors of M. S. Balayan

This figure shows the co-authorship network connecting the top 25 collaborators of M. S. Balayan. A scholar is included among the top collaborators of M. S. Balayan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. S. Balayan. M. S. Balayan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hepatitis E virus infection in chimpanzees: a retrospective analysis 2000 ·Archives of Virology ·Karen A. McCaustland, K. Krawczyński, James W. Ebert, M. S. Balayan, A. G. Andjaparidze, John Spelbring, Edwin H. Cook, Charles D. Humphrey, Patrice O. Yarbough, Michael O. Favorov, (unknown), Daniel W. Bradley, Betty H. Robertson	33
2	Taxonomy of the Caliciviruses 2000 ·The Journal of Infectious Diseases ·K. Y. Green, Tamie Ando, M. S. Balayan, Tamás Berke, Ian N. Clarke, Mary K. Estes, David O. Matson, Shuji Nakata, John D. Neill, Michael J. Studdert, (unknown)	384
3	Epidemiology of hepatitis E virus infection 1997 ·Journal of Viral Hepatitis ·M. S. Balayan	131
4	Antibody to hepatitis E virus in HIV‐infected individuals and AIDS patients 1997 ·Journal of Viral Hepatitis ·M. S. Balayan, (unknown), М. И. Михайлов, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	40
5	Public health control of hepatitis A: memorandum from a WHO meeting. 1995 ·PubMed ·M. S. Balayan, (unknown), Bertram Flehmig, Andrew Hall, Stanley M. Lemon, B. J. McMahon, Peter M. Ndumbe, G. Papaevangelou, Craig Shapiro, (unknown), (unknown), A. G. Andjaparidze, R. Bruce Aylward, (unknown), (unknown), David S. Fedson, Y. Z. Ghendon, (unknown), (unknown)	64
6	Serological survey on hepatitis E virus infection in an endemic area: diagnosis potential of enzyme immunoassay for detection of IgG antibody 1994 ·Clinical and Diagnostic Virology ·M. S. Balayan, (unknown), М. И. Михайлов, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	7
7	Hepatitis E virus in cultivated cells 1992 ·Archives of Virology ·(unknown), M. S. Balayan, (unknown), (unknown), (unknown), (unknown), (unknown)	30
8	Immunogenicity of inactivated purified tissue culture vaccine against hepatitis A (HepAvac) assessed in laboratory rodents 1992 ·Vaccine ·(unknown), (unknown), (unknown), M. S. Balayan	1
9	Simian hepatitis A virus (HAV) strain AGM-27: comparison of genome structure and growth in cell culture with other HAV strains 1991 ·Journal of General Virology ·S.A. Tsarev, Suzanne U. Emerson, M. S. Balayan, John R. Ticehurst, R H Purcell	53
10	Immunogenicity trial of inactivated hepatitis A virus vaccine in human volunteers 1991 ·Vaccine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), S. G. Drozdov, M. S. Balayan	8
11	Experimental hepatitis E infection in domestic pigs 1990 ·Journal of Medical Virology ·M. S. Balayan, (unknown), (unknown), (unknown), (unknown)	116
12	Variations in genome fragments coding for RNA polymerase in human and simian hepatitis A viruses 1989 ·FEBS Letters ·M. S. Balayan, (unknown), A. G. Andjaparidze, S.A. Tsarev, E. D. Sverdlov, Vladimir E. Chizhikov, Vladimir M. Blinov, (unknown)	9
13	Non-A, non-B fulminant viral hepatitis in France in returnees from Asia and Africa 1987 ·Digestive Diseases and Sciences ·Anita Margulies, Jacques Bernuau, M. S. Balayan, A. G. Andjaparidze, Frédéric Dubois, A Goudeau, B Rueff, J P Benhamou	13
14	Shifts in the rates and levels of antibody to hepatitis A virus associated with hepatitis A infection in children's communities 1987 ·European Journal of Epidemiology ·(unknown), M. S. Balayan	6
15	Antibody to hepatitis A virus after overt and asymptomatic hepatitis A infection 1986 ·European Journal of Epidemiology ·(unknown), M. S. Balayan	1
16	Improvement of methods for intratypic differentiation of polioviruses 1974 ·Archives of Virology ·M. P. Chumakov, (unknown), M. S. Balayan, (unknown), M. K. Voroshilova, (unknown), (unknown), (unknown)	4
17	Factors affecting the efficacy of live poliovirus vaccine in warm climates. Efficacy of type 1 Sabin vaccine administered together with antihuman gamma-globulin horse serum to breast-fed and artificially fed infants in Uganda. 1974 ·PubMed ·I Dömök, M. S. Balayan, (unknown), (unknown), (unknown), P.S.E.G. Harland	45
18	Behavior of poliovirus strains of different virulence under solid overlays 1970 ·Archives of Virology ·M. S. Balayan, M. K. Voroshilova, (unknown), (unknown)	3
19	Study of intratypic differences between type 2 polioviruses I. Relationship between neurovirulence, antigenicity and other properties determined on cells in vitro 1964 ·Virology ·M. S. Balayan, Elena A. Tolskaya, M. K. Voroshilova, (unknown)	7
20	Use of the Precipitin Test in the Diagnosis of Infections caused by ECHO and Coxsackie Viruses. 1963 ·Acta Virologica ·M. S. Balayan, Anastasiya Belyaeva, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact